In silico docking and ADME study of deketene curcumin derivatives (DKC) as an aromatase inhibitor or antagonist to the estrogen-alpha positive receptor (Erα+): potent application of breast cancer
Crossref DOI link: https://doi.org/10.1007/s11224-021-01871-2
Published Online: 2022-01-28
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shah, Vraj
Bhaliya, Jaydip
Patel, Gautam M.
Text and Data Mining valid from 2022-01-28
Version of Record valid from 2022-01-28
Article History
Received: 19 October 2021
Accepted: 13 December 2021
First Online: 28 January 2022
Declarations
:
: The authors declare no competing interests.